Home » Newsletters » BioWorld Science

BioWorld Science

July 11, 2003

View Archived Issues

IDM exercises option to license cancer epitopes from Epimmune

New inverse agonist at alpha2-adrenoceptors enhances cognition in rats

Use of dopamine D3 agonists in sexual dysfunction

ARYx describes novel delivery systems for analgesics

Novel Wyeth compounds that increase HDL cholesterol

Shire BioChem designs series for Flavivirus infections

Inhibitors of beta-secretase claimed for Rx of Alzheimer's disease and related disorders

Agents for herpesvirus infections reported in recent patent

First European approval for a drug to reduce risk of suicidal behavior

Novocell encapsulated islet cell implants successful in diabetic primates

Multikine may enhance success of radiation and chemotherapy in H&N cancer

Updated GOLD guidelines for COPD treatment include first-line tiotropium

CG-5601, a potential alternative to thalidomide for ocular inflammation

Evidence of antitumor efficacy found for PDX in NSCLC

FDA requests additional data for Follistim

DOR BioPharma executes worldwide license agreement for rights to ricin vaccine technology

Repaglinide vs. nateglinide in combination with metformin for type 2 diabetes

FDA advisory committee hands down positive opinion for Crestor

Pralnacasan phase IIb clinical trial begins enrollment

Preliminary findings reveal troponin I suppresses genes associated with angiogenesis

Potential residual effects described for rivastigmine in Alzheimer's disease after discontinuation

FibroGen awarded grant to develop cancer therapies

Myriad Genetics collaborates with the Mayo Clinic to develop novel Alzheimer's drugs

Clinical efficacy of tetrathiomolybdate in advanced kidney cancer

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 29, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...
Plasticity, properly parsed, provides psychiatric platform
BioWorld
If Benjamin Braddock, of The Graduate fame, were a young neuroscientist in the 21st century instead of a liberal arts graduate in 1967, the advice he received...